y*****l
发帖数: 5997 | 1 来自主题: _pennystock版 - PPHM Bio drug Niu!
Peregrine Completes Treatment of Last Patient in Phase II Cotara(R) Brain
Cancer Trial
Monday 12/20/2010 8:00 AM ET - Marketwire
Related Companies
Symbol Last %Chg
PPHM 2.01 21.09%
As of 11:29 AM ET 12/20/10
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage
biopharmaceutical company developing first-in-class monoclonal antibodies
for the treatment of cancer and viral infections, today announced the
completion of enrollment in the company's Phase II dose confirmation ... 阅读全帖 |
|
